- Home
- LXFR vs ETON Comparison
LXFR vs ETON Comparison
Compare LXFR & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXFR | ETON |
|---|---|---|
| Founded | 1898 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.4M | 683.7M |
| IPO Year | 2002 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LXFR | ETON |
|---|---|---|
| Price | $13.30 | $27.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $39.33 |
| AVG Volume (30 Days) | 181.1K | ★ 468.4K |
| Earning Date | 04-24-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $384,600,000.00 | $79,950,000.00 |
| Revenue This Year | N/A | $40.90 |
| Revenue Next Year | $5.01 | $47.23 |
| P/E Ratio | $47.71 | ★ N/A |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $9.46 | $13.09 |
| 52 Week High | $16.03 | $27.19 |
Technical Indicators
Market Signals| Indicator | LXFR | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 61.40 | 72.12 |
| Support Level | $12.44 | $16.38 |
| Resistance Level | $13.75 | N/A |
| Average True Range (ATR) | 0.39 | 1.28 |
| MACD | 0.23 | 0.08 |
| Stochastic Oscillator | 89.83 | 90.65 |
Price Performance
Historical ComparisonAbout LXFR Luxfer Holdings PLC
Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.